Scilex Holding Co
Scilex Holding Co
Insider Sentiment (TTM):
Last Purchase:2024-12-18Last Sale:2025-12-30Shares Purchased (TTM):0Shares Sold (TTM):9,657,300
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:871,693Shares Outstanding:6,891,000,000Institutional Ownership Pct.:0.01%
Earnings Market Reaction:
Filing Date:2026-05-20Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 5 | 1 | 4 | 6 | 3 | 0 | 7 | 2 | 4 | 2 | 34 | |||||
Marketable Securities | 0 | 6 | - | - | - | 0 | - | - | - | - | - | - | |||||
Accounts Receivable Net Current | 11 | 15 | 12 | 17 | 11 | 26 | 32 | 38 | 30 | 35 | 16 | 28 | |||||
Accounts And Other Receivables Net Current | 19 | - | - | - | - | - | - | - | - | - | - | - | |||||
Inventory Net | 5 | 5 | 1 | 3 | 3 | 2 | 2 | 3 | 3 | 4 | 4 | 3 | |||||
Other Prepaid Expense Current | 4 | 7 | 3 | 10 | 9 | 9 | 6 | 2 | 3 | 4 | 3 | 4 | |||||
Assets Current | 42 | 38 | 16 | 34 | 29 | 42 | 40 | 50 | 38 | 47 | 25 | 69 | |||||
Property Plant And Equipment Net | 13 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 14 | 15 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | |||||
Intangible Assets Net Excluding Goodwill | 60 | 59 | 30 | 31 | 31 | 32 | 33 | 34 | 35 | 36 | 38 | 39 | |||||
Investments | 5 | 1 | 0 | 2 | 2 | 2 | 2 | - | - | 0 | - | - | |||||
Equity Method Investment Aggregate Cost | 79 | 127 | 16 | - | - | 0 | - | - | - | - | - | - | |||||
Goodwill | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | |||||
Assets Noncurrent Other Than Noncurrent Investment… | 2 | 1 | 0 | 0 | 0 | 0 | 8 | 3 | 1 | 1 | 0 | 1 | |||||
Assets | 294 | 365 | 276 | 84 | 79 | 93 | 100 | 105 | 91 | 101 | 81 | 126 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 102 | 86 | 67 | 59 | 57 | 53 | 43 | 42 | 42 | 41 | 33 | 11 | |||||
Accrued Salaries Current | 4 | 3 | 0 | 2 | 2 | 2 | 1 | 4 | 4 | 3 | 3 | 3 | |||||
Other Accrued Liabilities Current | 248 | 232 | 213 | 193 | 168 | 163 | 142 | 125 | 104 | 90 | 66 | 48 | |||||
Other Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | - | 16 | |||||
Debt Current | 81 | 83 | 46 | 40 | 39 | 35 | 85 | 75 | 93 | 108 | 115 | - | |||||
Operating Lease Liability Current | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Current | 0 | 3 | - | - | - | 0 | - | - | - | - | - | 18 | |||||
Liabilities Current | 502 | 484 | 359 | 306 | 276 | 260 | 282 | 255 | 253 | 250 | 229 | 104 | |||||
Other Long Term Debt Noncurrent | 0 | 22 | 0 | 0 | 0 | 1 | 14 | 29 | 16 | 17 | 7 | - | |||||
Derivative Liabilities Noncurrent | 26 | 51 | 82 | 20 | 8 | 18 | 11 | 30 | 7 | 2 | 2 | 7 | |||||
Operating Lease Liability Noncurrent | 13 | 13 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 548 | 577 | 456 | 333 | 290 | 286 | 312 | 319 | 281 | 274 | 243 | 116 | |||||
Preferred Stock Value | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 799 | 797 | 785 | 453 | 448 | 455 | 431 | 426 | 415 | 408 | 397 | 444 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -7 | -6 | 3 | 6 | 6 | 6 | 5 | 2 | - | 0 | - | - | |||||
Retained Earnings Accumulated Deficit | -965 | -922 | -889 | -631 | -589 | -563 | -557 | -552 | -515 | -490 | -469 | -433 | |||||
Treasury Stock Value | -77 | -77 | -77 | -77 | -77 | -91 | -91 | -91 | -91 | -91 | -91 | - | |||||
Stockholders Equity | -254 | -208 | -180 | -249 | -211 | -193 | -211 | -215 | -190 | -173 | -163 | 10 | |||||
Minority Interest | -5 | -4 | -3 | - | - | 0 | - | - | - | - | - | - | |||||
Liabilities And Stockholders Equity | 294 | 365 | 276 | 84 | 79 | 93 | 100 | 105 | 91 | 101 | 81 | 126 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | 29 | 29 | 29 | 29 | 29 | 29 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | 29 | 29 | 29 | 29 | 29 | 29 | |||||
Common Stock Par Or Stated Value Per Share | 0.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | |||||
Common Stock Shares Issued | 8 | 8 | 8 | 7 | 7 | 7 | 192 | 3 | 166 | 160 | 0 | 149 | |||||
Shares Outstanding | 8 | 7 | 6 | 5 | 5 | 5 | 132 | 121 | 106 | 100 | 94 | 149 | |||||
Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 2 | 60 | 60 | 60 | 60 | 60 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 41.43% | 153.33% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 41.16% | 42.28% | 200.00% | 8.57% | -24.86% | -21.43% | 8.25% | -26.00% | -51.84% | 55.59% | 30.88% | 67.92% |
| 2024 | 35.40% | 133.54% | 78.88% | -20.61% | -25.19% | -25.88% | -17.82% | -22.72% | -42.54% | -46.41% | -47.79% | -43.66% |
| 2023 | - | - | - | -22.31% | -64.91% | -53.88% | -10.57% | 65.85% | 30.08% | 15.91% | -34.85% | -18.18% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.08 | 0.08 | 0.05 | 0.11 | 0.10 | 0.16 | 0.14 | 0.20 | 0.15 | 0.19 | 0.11 | 0.67 | |||||
| Quick Ratio | 0.07 | 0.07 | 0.04 | 0.10 | 0.09 | 0.15 | 0.13 | 0.19 | 0.14 | 0.17 | 0.09 | 0.64 | |||||
| Working Capital | -459.78M | -445.29M | -342.46M | -272.26M | -247.04M | -218.09M | -241.68M | -205.03M | -214.99M | -203.60M | -203.10M | -34.34M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -2.20 | -2.72 | -2.57 | -1.34 | -1.37 | -1.48 | -1.48 | -1.49 | -1.48 | -1.59 | -1.50 | 11.14 | |||||
| Interest Coverage TTM | -27.46 | -30.20 | -31.93 | -16.05 | -23.46 | -42.48 | -32.91 | -42.59 | -62.15 | -98.53 | -12.90 | -8.17 | |||||
| Debt Ratio | 1.87 | 1.58 | 1.65 | 3.97 | 3.68 | 3.07 | 3.10 | 3.05 | 3.08 | 2.71 | 3.02 | 0.92 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.18 | 0.13 | 0.21 | 0.47 | 0.60 | 0.58 | 0.61 | 0.44 | 0.53 | 0.50 | 0.50 | 0.35 | |||||
| Days Sales Outstanding TTM | 114.61 | 251.47 | 196.79 | 225.96 | 145.16 | 196.85 | 158.86 | 235.42 | 189.93 | 217.99 | 132.66 | 216.58 | |||||
| Receivables Turnover TTM | 3.18 | 1.45 | 1.85 | 1.62 | 2.51 | 1.85 | 2.30 | 1.55 | 1.92 | 1.67 | 2.75 | 1.69 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.06 | -0.05 | -0.05 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Free Cash Flow Per Share TTM | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 59.65% | 64.97% | 68.59% | 70.35% | 71.93% | 70.51% | 70.05% | 68.24% | 66.14% | 66.45% | 65.33% | 65.79% | |||||
| Operating Profit Margin TTM | -1,034.43% | -1,143.71% | -652.37% | -218.60% | -181.06% | -147.37% | -133.01% | -181.47% | -211.36% | -225.55% | -236.36% | -169.27% | |||||
| Net Profit Margin TTM | -1,162.43% | -1,118.60% | -844.35% | -197.45% | -76.65% | -128.66% | -159.10% | -233.88% | -229.47% | -244.59% | -263.61% | -133.71% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -33.22% | -46.54% | -26.82% | -12.98% | 7.79% | 21.07% | 22.02% | 9.41% | 12.54% | 22.90% | 73.08% | 215.24% | |||||
| Net Income Growth (1Y) | 912.74% | 364.80% | 288.36% | -26.53% | -64.00% | -36.32% | -26.36% | 91.38% | 102.50% | 389.35% | 39.82% | -42.57% | |||||
| EPS Growth (1Y) | 962.29% | 386.97% | 190.60% | -64.32% | -79.07% | -63.35% | -39.45% | 147.53% | 117.87% | 404.10% | 33.07% | -46.42% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -72.60 | -154.80 | -260.79 | -304.28 | -1,009.18 | -921.30 | -1,246.76 | -1,245.16 | -1,348.90 | -1,617.13 | -1,142.61 | -8,895.08 | |||||
| P/B TTM | -114.66 | -247.40 | -502.29 | -106.74 | -185.47 | -348.20 | -517.70 | -689.52 | -767.29 | -1,069.10 | -836.94 | 53,045.83 | |||||
| P/S TTM | 843.91 | 1,731.64 | 2,201.99 | 600.82 | 773.49 | 1,185.31 | 1,983.59 | 2,912.18 | 3,095.36 | 3,955.41 | 3,012.05 | 11,893.64 | |||||
| Market Cap | 28.58B | 52.39B | 88.87B | 26.58B | 39.22B | 67.08B | 109.40B | 148.04B | 145.62B | 184.89B | 136.14B | 552.58B | |||||
| Enterprise Value | 28.65B | 52.47B | 88.92B | 26.61B | 39.26B | 67.11B | 109.48B | 148.10B | 145.71B | 184.99B | 136.26B | 552.54B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -22.00M | 3.82M | 23.82M | 20.70M | 15.97M | 19.35M | 11.42M | 12.19M | -3.60M | -20.74M | -16.07M | -19.42M | |||||
| Net Debt | 77.43M | 78.31M | 44.80M | 35.77M | 33.64M | 31.60M | 76.52M | 65.70M | 90.15M | 103.70M | 113.24M | -35.13M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2025-12-30Sale
Owner: Scilex, Holding Co
Title: -
Shares: 9,657,300
Price/Share: $0.54
Value: $5,214,942.00
Shares Owned: 244,445,260
Relationship: TenPercentOwner
Ownership: Direct
2024-12-18Purchase
Owner: Shah, Jaisim
Title: See Remarks
Shares: 30,000
Price/Share: $0.46
Value: $13,800.00
Shares Owned: 139,333
Relationship: Director,Officer
Ownership: Direct
2024-10-31Purchase
Owner: Ji, Henry
Title: Executive Chairperson
Shares: 8,888
Price/Share: $0.94
Value: $8,354.72
Shares Owned: 320,161
Relationship: Director,Officer
Ownership: Direct
2024-10-29Purchase
Owner: Shah, Jaisim
Title: See Remarks
Shares: 32,000
Price/Share: $0.99
Value: $31,680.00
Shares Owned: 109,333
Relationship: Director,Officer
Ownership: Direct
2024-10-18Purchase
Owner: Chun, Jay
Title: -
Shares: 5,000
Price/Share: $0.95
Value: $4,750.00
Shares Owned: 112,500
Relationship: Director
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
0.01%
Inst. Shares: 871,693
Shares Outstanding: 6,891,000,000
2025-12-31
0.02%
Inst. Shares: 1,119,760
Shares Outstanding: 6,896,250,000
2025-09-30
0.01%
Inst. Shares: 727,898
Shares Outstanding: 7,252,500,000
2025-06-30
0.01%
Inst. Shares: 613,784
Shares Outstanding: 7,246,875,000
2025-03-31
0.61%
Inst. Shares: 44,089,059
Shares Outstanding: 7,228,125,000
Scilex Holding Co (SCLX) — SEC Financial Statements & Analysis
Scilex Holding Co (SCLX) is a biological products, (no diagnostic substances) company, incorporated in DE. Scilex Holding Co trades on SCLXW: Nasdaq as: SCLX: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Scilex Holding Co reported a -33.22% year-over-year revenue growth, a Gross Profit Margin of 59.65% (TTM), a Debt-to-Equity ratio of -2.20x, a Price-to-Sales (P/S) ratio of 843.91x (TTM), a Price-to-Book (P/B) ratio of -114.66 (TTM), at a market cap of $28.58B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -33.22%
- Gross Profit Margin TTM
- 59.65%
- Debt To Equity
- -2.20x
- P/S TTM
- 843.91x
- P/B TTM
- -114.66
- Market Cap
- $28.58B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Scilex Holding Co in?
Scilex Holding Co (SCLX) operates in the Biological Products, (No Diagnostic Substances) industry.
What is SCLX's market cap?
Scilex Holding Co (SCLX) has a market capitalization of $28.58B as of 2026-03-31.
What exchange does SCLX trade on?
Scilex Holding Co (SCLX) trades on the SCLXW: Nasdaq.
Where is Scilex Holding Co incorporated?
Scilex Holding Co is incorporated in DE.